A detailed history of Cwm, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Cwm, LLC holds 75 shares of AXGN stock, worth $1,292. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75
Previous 48 56.25%
Holding current value
$1,292
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025

BUY
$10.77 - $17.84 $290 - $481
27 Added 56.25%
75 $1,000
Q2 2025

Jul 25, 2025

SELL
$9.29 - $17.81 $1,319 - $2,529
-142 Reduced 74.74%
48 $1,000
Q1 2025

May 01, 2025

BUY
$14.56 - $20.11 $684 - $945
47 Added 32.87%
190 $4,000
Q4 2024

Feb 04, 2025

BUY
$12.47 - $17.19 $1,097 - $1,512
88 Added 160.0%
143 $2,000
Q3 2024

Oct 08, 2024

BUY
$7.52 - $14.69 $285 - $558
38 Added 223.53%
55 $1,000
Q2 2024

Jul 09, 2024

BUY
$5.67 - $8.06 $96 - $137
17 New
17 $0

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $729M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.